Jim Cramer used his Mad Money program to lay out an investing framework for the second half of 2026, urging investors to focus on broader market themes rather than chasing individual stocks. With the S&P 500 closing at an all-time high of 7,737 and the Dow crossing 54,000 for the first time, Cramer argued that identifying winning stocks becomes increasingly difficult without a macro-level perspective. The record levels come against a backdrop of continued corporate earnings growth, though they also raise the bar for sustained momentum.

"I love themes. They help you craft a portfolio of stocks with the wind at their backs, not in their faces," he said on the show.

Cramer identified five key themes drawn from the latest earnings season, each backed by data from corporate results.

Resilient Consumer Spending

Cramer's first theme centers on the continued strength of consumer spending, which accounts for roughly two-thirds of U.S. GDP. He noted that earnings reports from banks, travel companies, and retailers paint a more optimistic picture than broader economic headlines suggest.

"We've been told over and over that the consumer's totally stretched," he said. "The companies are saying otherwise."

His selections in this category include Capital One and American Express on the credit side, along with Ralph Lauren and Williams-Sonoma in retail. American Express reported a 9% increase in card member spending in the second quarter, marking its strongest growth in three years. Despite that data, Capital One is down 12.17% and American Express is down 8.54% in 2026. Williams-Sonoma stands out as the exception, gaining 34%.

AI Infrastructure

Cramer's second theme focuses on AI infrastructure, specifically semiconductor capital equipment manufacturers rather than memory chip buyers. These companies produce the specialized tools required to fabricate advanced chips, positioning them as suppliers to the broader AI buildout cycle. He named Lam Research, KLA, and Applied Materials as his preferred picks.

Bank of America raised its global cloud spending estimate to $1.18 trillion in 2027 and rates all three companies as buys. Applied Materials has surged over 100% in 2026, while Lam Research is up 68%.

Cybersecurity

The third theme is cybersecurity. Cramer said concerns that artificial intelligence would diminish demand for security software have proven unfounded, as threats have multiplied rather than retreated. High-profile data breaches at major corporations have underscored the urgency of enterprise security spending.

CrowdStrike reported a 26% year-over-year revenue increase to $1.39 billion in its most recent quarter. Palo Alto Networks is up over 102% in 2026, and CrowdStrike has gained 89%.

Mergers and Acquisitions

Cramer's fourth theme centers on mergers and acquisitions. He anticipates that companies will pursue deals while the regulatory environment remains accommodative, naming Goldman Sachs and Morgan Stanley as his investment bank plays. M&A activity often accelerates when corporate confidence in economic stability is high and financing conditions are favorable.

Goldman Sachs' investment banking division posted $3.4 billion in revenue in its latest quarter, its highest level since 2021.

Healthcare

The fifth theme is healthcare. Cramer highlighted Eli Lilly and Johnson & Johnson as opportunities for diversification beyond the technology sector. Eli Lilly shares have risen nearly 39% since its first-quarter earnings report, driven by strong demand for its obesity and diabetes medications. The GLP-1 drug class has emerged as one of the pharmaceutical industry's largest growth markets, with multiple analysts tracking expanding patient populations and new indications.

Risks and Outlook

Cramer acknowledged that each theme carries inherent risks. Elevated valuations on cybersecurity stocks, a potential slowdown in cloud spending, or a weakening labor market could each negatively impact the relevant positions.

"You can pick a travel stock, a semiconductor capital equipment maker, a cybersecurity company, something that works in the M&A world, or medtech and you'll greatly increase your chances of making money for the rest of 2026," he said.